Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study KM Musallam, HM Tamim, T Richards, DR Spahn, FR Rosendaal, ... The Lancet 378 (9800), 1396-1407, 2011 | 1401 | 2011 |
Thalassaemia AT Taher, DJ Weatherall, MD Cappellini The Lancet 391 (10116), 155-167, 2018 | 740 | 2018 |
Guidelines for the management of transfusion dependent thalassaemia (TDT) MD Cappellini, A Cohen, J Porter, A Taher, V Viprakasit Thalassaemia International Federation, 2014 | 667 | 2014 |
Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management MD Cappellini, J Comin‐Colet, A de Francisco, A Dignass, W Doehner, ... American journal of hematology 92 (10), 1068-1078, 2017 | 498 | 2017 |
Iron deficiency anaemia revisited MD Cappellini, KM Musallam, AT Taher Journal of internal medicine 287 (2), 153-170, 2020 | 493 | 2020 |
Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study AT Taher, KM Musallam, M Karimi, A El-Beshlawy, K Belhoul, S Daar, ... Blood, The Journal of the American Society of Hematology 115 (10), 1886-1892, 2010 | 459 | 2010 |
2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer D Farge, C Frere, JM Connors, C Ay, AA Khorana, A Munoz, B Brenner, ... The Lancet Oncology 20 (10), e566-e581, 2019 | 455 | 2019 |
Thalassemia intermedia: revisited A Taher, H Isma'eel, MD Cappellini Blood Cells, Molecules, and Diseases 37 (1), 12-20, 2006 | 448 | 2006 |
Prevalence of thromboembolic events among 8,860 patients with thalassaemia major and intermedia in the Mediterranean area and Iran A Taher, H Isma’eel, G Mehio, D Bignamini, A Kattamis, EA Rachmilewitz, ... Thrombosis and haemostasis 96 (10), 488-491, 2006 | 408 | 2006 |
Guidelines for the clinical management of thalassaemia MD Cappellini, A Cohen, A Eleftheriou, A Piga, J Porter, A Taher | 345 | 2013 |
Tailoring iron chelation by iron intake and serum ferritin: the prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias MD Cappellini, J Porter, A El-Beshlawy, CK Li, JF Seymour, M Elalfy, ... haematologica 95 (4), 557, 2010 | 345 | 2010 |
Iron overload in thalassemia: different organs at different rates AT Taher, AN Saliba Hematology 2014, the American Society of Hematology Education Program Book …, 2017 | 292 | 2017 |
Guidelines for the management of non transfusion dependent thalassaemia (NTDT) A Taher, E Vichinsky, K Musallam, MD Cappellini, V Viprakasit | 289 | 2014 |
How I treat transfusional iron overload AV Hoffbrand, A Taher, MD Cappellini Blood, The Journal of the American Society of Hematology 120 (18), 3657-3669, 2012 | 274 | 2012 |
Optimal management of β thalassaemia intermedia AT Taher, KM Musallam, MD Cappellini, DJ Weatherall British journal of haematology 152 (5), 512-523, 2011 | 270 | 2011 |
A phase 3 trial of luspatercept in patients with transfusion-dependent β-thalassemia MD Cappellini, V Viprakasit, AT Taher, P Georgiev, KHM Kuo, T Coates, ... New England Journal of Medicine 382 (13), 1219-1231, 2020 | 261 | 2020 |
β-Thalassemias AT Taher, KM Musallam, MD Cappellini New England Journal of Medicine 384 (8), 727-743, 2021 | 251 | 2021 |
Clinical experience with fetal hemoglobin induction therapy in patients with β-thalassemia KM Musallam, AT Taher, MD Cappellini, VG Sankaran Blood, The Journal of the American Society of Hematology 121 (12), 2199-2212, 2013 | 240 | 2013 |
Paraspinal extramedullary hematopoiesis in patients with thalassemia intermedia R Haidar, H Mhaidli, AT Taher European Spine Journal 19, 871-878, 2010 | 237 | 2010 |
Efficacy of deferasirox in reducing and preventing cardiac iron overload in β-thalassemia DJ Pennell, JB Porter, MD Cappellini, A El-Beshlawy, LL Chan, Y Aydinok, ... Blood, The Journal of the American Society of Hematology 115 (12), 2364-2371, 2010 | 236 | 2010 |